Intra-articular injection of ketorolac in the rat knee joint: effect on articular cartilage and synovium.
We have investigated the effects of intra-articular (i.a.) administration of ketorolac in the rat knee joint. Thirty Sprague-Dawley rats were given 0.25 ml of a standard preparation of ketorolac trometamol (10 mg ml-1) by injection into the right knee joint and 0.25 ml of 0.9% physiological saline solution by injection into the left knee as a control. Ten rats were killed at 24 h, 10 at 48 h and 10 at 5 days after injection. The joints were prepared and sectioned for histological examination. There was significantly more inflammation in those knees that had received i.a. ketorolac at all times of examination, with the most severe changes occurring 5 days after injection. A further group of 10 rats were given 0.25 ml of 10% w/v ethanol in physiological saline (similar to the vehicle for parenteral ketorolac) injected into the knee joint, with a 0.9% saline control injected in the other knee. These rats were then killed at 5 days (as this was the time interval after which we found the maximum inflammatory response in the earlier phase of our study). The joints were prepared and examined histologically. We feel that the absence of inflammatory changes in these joints make it unlikely that ethanol was responsible for the inflammation produced by ketorolac injection.
Irwin
M G
MG
Department of Anaesthesiology, University of Hong Kong.
Cheung
K M
KM
Nicholls
J M
JM
Thompson
N
N
D000700:Analgesics / Q000633:toxicity*; D000818:Animals; D001168:Arthritis / Q000139:chemically induced* / Q000473:pathology; D002358:Cartilage, Articular / Q000187:drug effects / Q000473:pathology; D016861:Cyclooxygenase Inhibitors / Q000633:toxicity*; D007270:Injections, Intra-Articular; D020911:Ketorolac Tromethamine; D007719:Knee Joint / Q000187:drug effects* / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013583:Synovial Membrane / Q000187:drug effects / Q000473:pathology; D014046:Tolmetin / Q000031:analogs & derivatives* / Q000633:toxicity; D014325:Tromethamine / Q000031:analogs & derivatives* / Q000633:toxicity
D000700:Analgesics; D016861:Cyclooxygenase Inhibitors; D014325:Tromethamine; D020911:Ketorolac Tromethamine; D014046:Tolmetin